Czechia, June 4 -- Czechia based Gilead Sciences s.r.o. has secured contract from Institut klinicke a experimentalni mediciny for Antivirals for systemic use Antivirotika HCV Sofosbuvir - Velpatasvir - II . The value of the contract is worth 14189044870 CZK .
Published by HT Digital Content Services with permission from Pivotal Sources....